Results 151 to 160 of about 290,884 (252)

Effects of adding transcutaneous vagus nerve stimulation to vestibular rehabilitation on dizziness and postural control in vestibular migraine: a randomized clinical trial. [PDF]

Sci Rep
Farahani A, Adel Ghahraman M, Togha M, Malmir K, Jalaie S.   +4 more
europepmc   +1 more source

Efficacy of EGb 761^® and Betahistine in Treatment of Dizziness/Vertigo: A Randomized Double-Blind Controlled Trial. [PDF]

J Otolaryngol Head Neck Surg
Jianbunjongkit N, Nattarangsi W, Teeravanittrakul P.   +2 more
europepmc   +1 more source

Likelihood and Predictors of Acute Findings on CTA Head and Neck for Neurologic Presentations to the Emergency Department. [PDF]

Neurol Clin Pract
Gaini R, Reyes SL, Muqeem T, Unnithan S, Al-Khalidi H, Kranz PG, Morgenlander JC.   +6 more
europepmc   +1 more source

Hypotensive Episodes Precede Cognitive Fluctuations in Parkinson's Disease Dementia

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Cognitive fluctuations (CFs) are a disabling feature in Parkinson's disease dementia (PDD) and contribute to caregiver burden. The relationship between CFs and neurogenic orthostatic hypotension (nOH), a common autonomic complication in PDD, has not been adequately examined.
Jorge Patino, Kevin Duque, Jesus Abanto, Aaron Bloemer, Heba Deraz, Alberto J. Espay, Abhimanyu Mahajan   +6 more
wiley   +1 more source

Towards a Personalized Vestibular Assessment in Older Patients with Cochlear Implant. [PDF]

J Pers Med
Di Cesare T, Picciotti PM, Di Nardo W, Rodolico D, Galli J.   +4 more
europepmc   +1 more source

Treatment Continuation and Long‐Term Outcomes of Perampanel in Primary Orthostatic Tremor; A Cohort Study

Movement Disorders Clinical Practice, EarlyView.
Background Primary orthostatic tremor (POT) is a rare hyperkinetic movement disorder with limited and largely ineffective treatment options. Perampanel has been suggested as a therapy, but has so far only been investigated in small studies with short duration.
Wietske A. Babeliowsky, Bart Swinnen, Jeroen Hoogland, Rob M.A. de Bie, Anne‐Fleur van Rootselaar   +4 more
wiley   +1 more source

U.S. Emergency Department Visits for Dizziness and Vertigo From 2016 to 2022. [PDF]

Acad Emerg Med
Miulli MM, Kim HS.
europepmc   +1 more source

An Open‐Label Phase 1b Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of ANX005 in Patients with Huntington's Disease

Movement Disorders, EarlyView.
Complement activation is implicated in Huntington's disease; ANX005 is a potent inhibitor of component C1q. ANX005 exhibited a generally manageable safety profile with rapid reduction in C1q in the cerebrospinal fluid. Functional ability on composite Unified Huntington's Disease Rating Scale and total functional capacity was maintained, with potential ...
Rajeev Kumar, Pinky Agarwal, Karen Anderson, Daniel Claassen, Marissa Dean, Andrew Duker, Burton Scott, Benjamin Hoehn, Ann Mongan, Ping Lin, Ellen Cahir‐McFarland, Lori Taylor, Glenn Morrison, Ted Yednock, Sanjay Keswani, Henk‐Andre Kroon   +15 more
wiley   +1 more source

The efficacy of rimegepant for the acute treatment of vestibular migraine. [PDF]

Sci Rep
Chu H, Pan J, Huang C.
europepmc   +1 more source

Are Cochlear Implants Indicated in the Advanced Aging Population?

The Laryngoscope, EarlyView.
India Jackson, Tiffany Peng Hwa, Michael Ruckenstein   +2 more
wiley   +1 more source